- Current role of biological treatment in Wegener's granulomatosis2011 | Second Faculty of Medicine
- Complement Inhibition in ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Pathophysiology of ANCA-associated vasculitis2020 | First Faculty of Medicine
- Genetically distinct subsets within ANCA-associated vasculitis2012 | First Faculty of Medicine
- Diabetes insipidus caused by ANCA associated vasculitis2022 | First Faculty of Medicine
- Exposure to Silica and Risk of ANCA-Associated Vasculitis2006 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Treatment of refractory ANCA-associated vasculitis with rituximab. Commentary on: Arthritis and Reheumatism 60,2009,s.2156-21682009 | First Faculty of Medicine
- Pitfalls of diagnosis of ANCA-associated vasculitis - case report2020 | First Faculty of Medicine, Central Library of Charles University
- Long-term follow-up of lymphocyte subpopulations and intracellular cytokines in patients with ANCA-associated vasculitis treated with rituximabPublication without faculty affiliation
- Asbestos and ANCA associated vasculitis2001 | Central Library of Charles University, Second Faculty of Medicine
- Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts2017 | First Faculty of Medicine
- Exposure to SiO2 and ANCA - associated vasculitisPublication without faculty affiliation
- Exposure to SiO2 and ANCA-associated vasculitisPublication without faculty affiliation
- Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study2021 | First Faculty of Medicine
- Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis2023 | First Faculty of Medicine
- Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis2022 | First Faculty of Medicine
- Advantages of anti-myeloperoxidase and anti-proteinase-3 antibodies detection by chemiluminescence method in patients with ANCA-associated vasculitis2018 | First Faculty of Medicine
- Exposure to silica and ANCA-associated vasculitis (2)Publication without faculty affiliation
- Exposure to silica and risk of ANCA-associated vasculitis2006 | First Faculty of Medicine
- Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study2023 | First Faculty of Medicine
- Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine2021 | First Faculty of Medicine
- ANCA associated vasculitis anti PR 3 amntibodies is genetically distinct from anti-MPO antibody -relatid vase. Commentary on:NEJM 367,2012,214-2232012 | First Faculty of Medicine
- Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis2023 | First Faculty of Medicine
- Daily oral versus pulse intravenous cyclophosphamide in the theraphy of ANCA-associated vasculitis-preliminary single center experience2004 | First Faculty of Medicine
- Avacopan in the treatment of ANCA-associated vasculitis2018 | First Faculty of Medicine
- Circulating endothelial progenitor cells in patients with ANCA -associated vasculitisPublication without faculty affiliation
- Treatment of ANCA associated vasculitis2008 | First Faculty of Medicine
- Silica and Asbestos Exposure in ANCA-Associated Vasculitis with Pulmonary Involvement2005 | Second Faculty of Medicine
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis2020 | First Faculty of Medicine